genprowebdirectory
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2021
Macular edema
Drug Discovery
Adverum Confirms Patient Loses Sight in Eye Treated with Its Gene Therapy
Alex Philippidis
-
April 29, 2021
0
Featured
Clearside Scraps Xipere for RVO after Phase III Failure; Shares Tumble 58%
Alex Philippidis
-
November 5, 2018
0
Industry News
Development of Eye Disease Combination Therapy Halted by Regeneron, Bayer after Phase II Failures
GEN Staff Writer
-
November 27, 2017
0
Industry News
Roche to License Eleven Bio’s IL-6 Antagonist Antibody Technology
GEN Staff Writer
-
June 13, 2016
0
News
Allergan Swallows Poison Pill as Valeant Plans R&D Cuts
GEN Staff Writer
-
April 23, 2014
0
News
FDA Approves Lucentis for Diabetic Macular Edema
GEN Staff Writer
-
August 13, 2012
0
News
Chinese Regulator Clears Novartis’ Wet AMD Drug Lucentis
GEN Staff Writer
-
January 18, 2012
0
News
Akebia Spins out Aerpio to Develop Tie-2 Activators and HIF-1a Stabilizers
GEN Staff Writer
-
January 9, 2012
0
Drug Discovery
JDRF Provides $2.2M Support for KalVista’s Kallikrein Inhibitor DME Drug
GEN Staff Writer
-
January 9, 2012
0
Drug Discovery
ViroPharma Gives Intellect Neurosciences $6.5M for Exclusive Worldwide Rights to OX1
GEN Staff Writer
-
September 30, 2011
0
1
2
3
Page 1 of 3
Scroll Up
Scroll Up
